GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Price-to-Free-Cash-Flow

Proteomics International Laboratories (ASX:PIQ) Price-to-Free-Cash-Flow : N/A (As of May. 22, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Price-to-Free-Cash-Flow?

As of today (2025-05-22), Proteomics International Laboratories's share price is A$0.41. Proteomics International Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.04. Hence, Proteomics International Laboratories's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Proteomics International Laboratories's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:PIQ's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.09
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Proteomics International Laboratories's Free Cash Flow per Share for the six months ended in Dec. 2024 was A$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-0.04.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -26.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -23.30% per year.

During the past 10 years, Proteomics International Laboratories's highest 3-Year average Free Cash Flow per Share Growth Rate was 11.20% per year. The lowest was -36.90% per year. And the median was -8.10% per year.


Proteomics International Laboratories Price-to-Free-Cash-Flow Historical Data

The historical data trend for Proteomics International Laboratories's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Price-to-Free-Cash-Flow Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Proteomics International Laboratories's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Proteomics International Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteomics International Laboratories's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's Price-to-Free-Cash-Flow falls into.


;
;

Proteomics International Laboratories Price-to-Free-Cash-Flow Calculation

Proteomics International Laboratories's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.41/-0.042
=N/A

Proteomics International Laboratories's Share Price of today is A$0.41.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteomics International Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Proteomics International Laboratories  (ASX:PIQ) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Proteomics International Laboratories Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteomics International Laboratories Business Description

Traded in Other Exchanges
N/A
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories Headlines

No Headlines